CTMX
CytomX Therapeutics Inc

4,393
Mkt Cap
$721.79M
Volume
51.00
52W High
$4.62
52W Low
$0.40
PE Ratio
10.19
CTMX Fundamentals
Price
$4.26
Prev Close
$4.16
Open
$4.18
50D MA
$3.92
Beta
1.46
Avg. Volume
3.88M
EPS (Annual)
$0.3761
P/B
6.55
Rev/Employee
$1.14M
Loading...
Loading...
News
all
press releases
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC
Precision Wealth Strategies LLC bought a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the third quarter, according to the company in its most recent 13F...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Inspire Investing LLC Acquires Shares of 522,482 CytomX Therapeutics, Inc. $CTMX
Inspire Investing LLC bought a new position in CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·7d ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven analysts that are presently covering the stock...
MarketBeat·7d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Trading Up 5.4% - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 5.4% - What's Next...
MarketBeat·9d ago
News Placeholder
5,769,230 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Vivo Capital LLC
Vivo Capital LLC bought a new position in CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission...
MarketBeat·24d ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat·1mo ago
News Placeholder
Franklin Resources Inc. Invests $13.10 Million in CytomX Therapeutics, Inc. $CTMX
Franklin Resources Inc. bought a new stake in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·1mo ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 7.1% - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 7.1% - Here's Why...
MarketBeat·1mo ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down - Should You Sell?
CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down - What's Next...
MarketBeat·2mo ago
News Placeholder
What is HC Wainwright's Forecast for CTMX FY2025 Earnings?
CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) - Investment analysts at HC Wainwright decreased their FY2025 earnings estimates for CytomX Therapeutics in a research note issued to investors...
MarketBeat·2mo ago
<
1
2
...
>

Latest CTMX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.